Yabao Pharmaceutical Group Co., Ltd (600351.SS) — Stock Score Summary

Yabao Pharmaceutical Group Co., Ltd (600351.SS) has a MoatMap StockRank of 98/100 based on Quality (80/100), Value (75/100), and Momentum (42/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$0.91
Market Cap$657M
P/E (TTM)13.89
Price/Book1.55
Return on Equity10.5%
Return on Invested Capital13.0%
Debt/Equity1.32
Gross Margin51.3%
Operating Margin23.7%
Revenue Growth-6.9%
Dividend Yield7.8%
Free Cash Flow$10M

Yabao Pharmaceutical Group Co., Ltd operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Yabao Pharmaceutical Group Co., Ltd’s (600351.SS) StockRank?
MoatMap’s StockRank for Yabao Pharmaceutical Group Co., Ltd (600351.SS) is 98/100, with a Strong Buy signal. It is a composite of Quality (80), Value (75), and Momentum (42) factor ranks across MoatMap’s 19,000+ stock universe.
Does Yabao Pharmaceutical Group Co., Ltd have an economic moat?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) has a Quality factor score of 80/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Yabao Pharmaceutical Group Co., Ltd a buy, hold, or sell?
MoatMap’s current signal for Yabao Pharmaceutical Group Co., Ltd (600351.SS) is Strong Buy, based on a StockRank of 98/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Yabao Pharmaceutical Group Co., Ltd in?
Yabao Pharmaceutical Group Co., Ltd (600351.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).